Literature DB >> 8220895

Evidence for sympathetic neurotransmission through presynaptic N-type calcium channels in human saphenous vein.

F Fabi1, M Chiavarelli, L Argiolas, R Chiavarelli, P del Basso.   

Abstract

1. The specific type(s) of voltage-sensitive calcium channels (VSCCs) involved in sympathetic neurotransmission have not yet been characterized in human vascular tissues. We therefore examined the functional role of the N- and L-type VSCCs in human saphenous veins. 2. Contractile response curves for transmural nerve stimulation (TNS) and for exogenously administered noradrenaline (NA) were obtained in superfused saphenous vein rings. The contractions induced by TNS, but not by NA, were inhibited by 1 microM tetrodotoxin and by 10 microM guanethidine. Both responses were substantially reduced by 1 microM phentolamine, indicating that the contractions evoked by TNS were mediated by endogenous NA released from noradrenergic nerves. 3. In the presence of 2 microM omega-conotoxin GVIA (omega Conus Geographus toxin, fraction VI A; omega-CgTx), a polypeptide with specific inhibitory activity on N- and L-type calcium channels, the neurally evoked contractions were almost completely abolished. In contrast, the responses induced by exogenous NA were not affected by the neurotoxin, thus providing evidence of the exclusive presynaptic action of omega-CgTx. 4. In the presence of the calcium antagonist verapamil (10 microM), which selectively blocks L-type VSCCs, the contractions induced by both TNS and NA were diminished to the same extent, suggesting that the organic calcium blocker is active only at the postjunctional level. 5. It is concluded that N-type calcium channels are the main pathway of calcium entry controlling the functional responses induced by activating sympathetic nerves; the role of L-type channels appears to be limited to the postjunctional level, modulating smooth muscle contractions.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8220895      PMCID: PMC2176020          DOI: 10.1111/j.1476-5381.1993.tb13814.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  25 in total

Review 1.  Calcium channel-targeted polypeptide toxins.

Authors:  B M Olivera; J S Imperial; L J Cruz; V P Bindokas; V J Venema; M E Adams
Journal:  Ann N Y Acad Sci       Date:  1991       Impact factor: 5.691

2.  Three types of neuronal calcium channel with different calcium agonist sensitivity.

Authors:  M C Nowycky; A P Fox; R W Tsien
Journal:  Nature       Date:  1985 Aug 1-7       Impact factor: 49.962

Review 3.  Multiple calcium channels and neuronal function.

Authors:  R J Miller
Journal:  Science       Date:  1987-01-02       Impact factor: 47.728

4.  Omega-conotoxin: direct and persistent blockade of specific types of calcium channels in neurons but not muscle.

Authors:  E W McCleskey; A P Fox; D H Feldman; L J Cruz; B M Olivera; R W Tsien; D Yoshikami
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

5.  Membrane currents in adult rat superior cervical ganglia in dissociated tissue culture.

Authors:  N V Marrion; T G Smart; D A Brown
Journal:  Neurosci Lett       Date:  1987-06-01       Impact factor: 3.046

6.  Calcium entry and transmitter release at voltage-clamped nerve terminals of squid.

Authors:  G J Augustine; M P Charlton; S J Smith
Journal:  J Physiol       Date:  1985-10       Impact factor: 5.182

7.  Effects of Ca antagonists on the norepinephrine release and contractile responses of isolated canine saphenous veins to high KCl.

Authors:  Y Takata; H Kato
Journal:  Jpn J Pharmacol       Date:  1985-04

8.  Effects of calcium antagonists on release of [3H]noradrenaline in rabbit aorta.

Authors:  H Karaki; H Nakagawa; N Urakawa
Journal:  Eur J Pharmacol       Date:  1984-06-01       Impact factor: 4.432

9.  Effect of calcium antagonists on adrenergic mechanisms in canine saphenous veins.

Authors:  R L Jayakody; C T Kappagoda; M P Senaratne
Journal:  J Physiol       Date:  1986-03       Impact factor: 5.182

Review 10.  Calcium antagonism and calcium entry blockade.

Authors:  T Godfraind; R Miller; M Wibo
Journal:  Pharmacol Rev       Date:  1986-12       Impact factor: 25.468

View more
  6 in total

1.  Effects of omega-conotoxin GVIA and diltiazem on double peaked vasoconstrictor responses to periarterial electric nerve stimulation in isolated canine splenic artery.

Authors:  X P Yang; S Chiba
Journal:  Br J Pharmacol       Date:  2000-01       Impact factor: 8.739

2.  Effects of N-, P- and Q-type neuronal calcium channel antagonists on mammalian peripheral neurotransmission.

Authors:  C E Wright; J A Angus
Journal:  Br J Pharmacol       Date:  1996-09       Impact factor: 8.739

3.  Effects of cilnidipine, a novel dihydropyridine calcium antagonist, on autonomic function, ambulatory blood pressure and heart rate in patients with essential hypertension.

Authors:  J Minami; Y Kawano; Y Makino; H Matsuoka; S Takishita
Journal:  Br J Clin Pharmacol       Date:  2000-12       Impact factor: 4.335

4.  Further insights into the antinociceptive potential of a peptide disrupting the N-type calcium channel-CRMP-2 signaling complex.

Authors:  Sarah M Wilson; Joel M Brittain; Andrew D Piekarz; Carrie J Ballard; Matthew S Ripsch; Theodore R Cummins; Joyce H Hurley; May Khanna; Nathan M Hammes; Brian C Samuels; Fletcher A White; Rajesh Khanna
Journal:  Channels (Austin)       Date:  2011-09-01       Impact factor: 2.581

5.  Nerve-perivascular fat communication as a potential influence on the performance of blood vessels used as coronary artery bypass grafts.

Authors:  Andrzej Loesch; Michael R Dashwood
Journal:  J Cell Commun Signal       Date:  2017-06-10       Impact factor: 5.782

Review 6.  N-type calcium channel and renal injury.

Authors:  Lei Bai; Shichao Sun; Yao Sun; Fujun Wang; Akira Nishiyama
Journal:  Int Urol Nephrol       Date:  2022-04-13       Impact factor: 2.266

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.